Lead author Jan Lagendijk (left) and first author Bas Raaymakers from UMC Utrecht. (Courtesy: UMC Utrecht) A research paper describing the first clinical use of a 1.5 T MRI-Linac for MRI-guided ...
BOSTON — On a recent Wednesday morning at Brigham and Women’s Hospital, a team of two radiation therapists, a radiation oncologist, and a physicist sat glued to a screen filled with black-and-white ...
Canadian scientists are developing a new technology that integrates two existing medical devices -- medical linear accelerators, or "linacs," which produce powerful X-rays for treating cancer, and ...
CLEVELAND, Oct. 14, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Louis Stokes Cleveland VA Medical Center in Cleveland, Ohio has purchased the MRIdian® Linac MRI-Guided ...
A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. The study, led by researchers at Sylvester Comprehensive Cancer Center ...
Viewray Inc. received FDA clearance for the Mridian Linac system, a device that allows clinicians to visualize in real time the movement of tumors and organs during radiation treatment. The Oakwood, ...
Canadian scientists at the University of Alberta's Cross Cancer Institute are developing a new technology that integrates two existing medical devices -- medical linear accelerators, or "linacs," ...
Radiation therapy plan from the MRI-linac treatment planning system. (Courtesy: Pract. Radiat. Oncol. 10.1016/j.prro.2019.02.003) Researchers in the US have used MRI-guided radiation therapy (MR-IGRT) ...
A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. The study, led by researchers at Sylvester Comprehensive Cancer Center ...
Daily imaging used to track cancer tumor changes can allow for more rapid radiation treatment adaptation, according to a study published Sept. 30 in International Journal of Radiation Oncology-Biology ...
The study, led by Eric A. Mellon, M.D., Ph.D. and Kaylie Cullison, Ph.D., at Sylvester Comprehensive Cancer Center, is the first to quantify tumor changes in glioblastoma patients receiving MRI-guided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results